BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 10709732)

  • 1. Autoimmune lymphoproliferative syndrome (ALPS) in a child from consanguineous parents: a dominant or recessive disease?
    van der Burg M; de Groot R; Comans-Bitter WM; den Hollander JC; Hooijkaas H; Neijens HJ; Berger RM; Oranje AP; Langerak AW; van Dongen JJ
    Pediatr Res; 2000 Mar; 47(3):336-43. PubMed ID: 10709732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined germline and somatic human FADD mutations cause autoimmune lymphoproliferative syndrome.
    Pellé O; Moreno S; Lorenz MR; Riller Q; Fuehrer M; Stolzenberg MC; Maccari ME; Lenoir C; Cheminant M; Hinze T; Hebart HF; König C; Schvartz A; Schmitt Y; Vinit A; Henry E; Touzart A; Villarese P; Isnard P; Neveux N; Landman-Parker J; Picard C; Fouyssac F; Neven B; Grimbacher B; Speckmann C; Fischer A; Latour S; Schwarz K; Ehl S; Rieux-Laucat F; Rensing-Ehl A; Magérus A
    J Allergy Clin Immunol; 2024 Jan; 153(1):203-215. PubMed ID: 37793571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the potential role of CASPASE-10 mutations in the development of autoimmune lymphoproliferative syndrome.
    Consonni F; Moreno S; Vinuales Colell B; Stolzenberg MC; Fernandes A; Parisot M; Masson C; Neveux N; Rosain J; Bamberger S; Vigue MG; Malphettes M; Quartier P; Picard C; Rieux-Laucat F; Magerus A
    Cell Death Dis; 2024 May; 15(5):315. PubMed ID: 38704374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.
    Dowdell KC; Niemela JE; Price S; Davis J; Hornung RL; Oliveira JB; Puck JM; Jaffe ES; Pittaluga S; Cohen JI; Fleisher TA; Rao VK
    Blood; 2010 Jun; 115(25):5164-9. PubMed ID: 20360470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal biomarkers predict complex FAS or FADD defects missed by exome sequencing.
    Rensing-Ehl A; Lorenz MR; Führer M; Willenbacher W; Willenbacher E; Sopper S; Abinun M; Maccari ME; König C; Haegele P; Fuchs S; Castro C; Kury P; Pelle O; Klemann C; Heeg M; Thalhammer J; Wegehaupt O; Fischer M; Goldacker S; Schulte B; Biskup S; Chatelain P; Schuster V; Warnatz K; Grimbacher B; Meinhardt A; Holzinger D; Oommen PT; Hinze T; Hebart H; Seeger K; Lehmberg K; Leahy TR; Claviez A; Vieth S; Schilling FH; Fuchs I; Groß M; Rieux-Laucat F; Magerus A; Speckmann C; Schwarz K; Ehl S;
    J Allergy Clin Immunol; 2024 Jan; 153(1):297-308.e12. PubMed ID: 37979702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Expression of Proteins in an Atypical Presentation of Autoimmune Lymphoproliferative Syndrome.
    Delgadillo DM; Céspedes-Cruz AI; Ríos-Castro E; Rodríguez Maldonado MG; López-Nogueda M; Márquez-Gutiérrez M; Villalobos-Manzo R; Ramírez-Reyes L; Domínguez-Fuentes M; Tapia-Ramírez J
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells.
    Staniek J; Kalina T; Andrieux G; Boerries M; Janowska I; Fuentes M; Díez P; Bakardjieva M; Stancikova J; Raabe J; Neumann J; Schwenk S; Arpesella L; Stuchly J; Benes V; García Valiente R; Fernández García J; Carsetti R; Piano Mortari E; Catala A; de la Calle O; Sogkas G; Neven B; Rieux-Laucat F; Magerus A; Neth O; Olbrich P; Voll RE; Alsina L; Allende LM; Gonzalez-Granado LI; Böhler C; Thiel J; Venhoff N; Lorenzetti R; Warnatz K; Unger S; Seidl M; Mielenz D; Schneider P; Ehl S; Rensing-Ehl A; Smulski CR; Rizzi M
    Sci Immunol; 2024 Jan; 9(91):eadj5948. PubMed ID: 38215192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations.
    Vaishnaw AK; Orlinick JR; Chu JL; Krammer PH; Chao MV; Elkon KB
    J Clin Invest; 1999 Feb; 103(3):355-63. PubMed ID: 9927496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Eruption Associated with Sirolimus in a Child with FAS-Associated Autoimmune Lymphoproliferative Syndrome.
    Trayer J; Browne F; O'Sullivan M; Leahy TR
    J Clin Immunol; 2023 Oct; 43(7):1537-1539. PubMed ID: 37369913
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered regulatory mechanisms governing cell survival in children affected with clustering of autoimmune disorders.
    Palamaro L; Giardino G; Santamaria F; Ramenghi U; Dianzani U; Pignata C
    Ital J Pediatr; 2012 Sep; 38():42. PubMed ID: 22971828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune lymphoproliferative immunodeficiencies (ALPIDs): A proposed approach to redefining ALPS and other lymphoproliferative immune disorders.
    Magerus A; Rensing-Ehl A; Rao VK; Teachey DT; Rieux-Laucat F; Ehl S
    J Allergy Clin Immunol; 2024 Jan; 153(1):67-76. PubMed ID: 37977527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous
    Elgharbawy FM; Karim MY; Soliman DS; Hassan AS; Sudarsanan A; Gad A
    Front Pediatr; 2023; 11():1150179. PubMed ID: 37152306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ALPS, FAS, and beyond: from inborn errors of immunity to acquired immunodeficiencies.
    Consonni F; Gambineri E; Favre C
    Ann Hematol; 2022 Mar; 101(3):469-484. PubMed ID: 35059842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
    Gámez-Díaz L; Grimbacher B
    Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genetic landscape of the FAS pathway deficiencies.
    Magerus A; Bercher-Brayer C; Rieux-Laucat F
    Biomed J; 2021 Aug; 44(4):388-399. PubMed ID: 34171534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete penetrance in primary immunodeficiency: a skeleton in the closet.
    Gruber C; Bogunovic D
    Hum Genet; 2020 Jun; 139(6-7):745-757. PubMed ID: 32067110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
    Rieux-Laucat F; Magérus-Chatinet A; Neven B
    J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats.
    Aberdein D; Munday JS; Gandolfi B; Dittmer KE; Malik R; Garrick DJ; Lyons LA;
    Mamm Genome; 2017 Feb; 28(1-2):47-55. PubMed ID: 27770190
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.